Last checked at 
ABUJA, Oct 14 (Reuters) - Nigeria has received 501,600 doses
of AstraZeneca's COVID-19 vaccine from the French
government through the COVAX vaccine-sharing facility, a senior
health official said on Thursday.
Faisal Shuaib, head of the National Primary Health Care
Development Agency, said the country also received 434,400 doses
of Johnson and Johnson vaccine from the African Union.
Both supplies were received last week, Shuaib said, adding
that more were expected through the COVAX facility and the
African Union.
The COVAX facility, backed by the World Health Organization
and the GAVI vaccine alliance, aims to secure billions of doses
for lower-income countries by the end of 2021.
About 2.3% of Nigerians or 2.54 million people have been
fully vaccinated as of Thursday, while 4.7% of the population
have received at least one dose of COVID-19 vaccine, Shuaib
said.
"With more vaccines arriving in the country, it is my
fervent hope that more people will turn up ... so that Nigeria
can rapidly progress towards attaining herd immunity," Shuaib
said.
From Dec. 1, Nigerian civil servants will be require to show
proof of vaccination against COVID-19 or a negative test for the
disease to gain access to their offices, a presidential
committee has said.
Nigeria, which has not tested widely for COVID-19, has so
far recorded 208,404 confirmed infections and 2,761 deaths from
the virus.
(Reporting by Camillus Eboh; Writing by Chijioke Ohuocha;
Editing by Peter Cooney)
